AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Law, M.
Right arrow Articles by Johnson, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Law, M.
Right arrow Articles by Johnson, G.

Comparing Perfusion Metrics Obtained from a Single Compartment Versus Pharmacokinetic Modeling Methods Using Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade

M. Lawa,b, R. Younga, J. Babba, M. Rada, T. Sasakia, D. Zagzagc and G. Johnsona

a Department of Radiology, NYU Medical Center, New York, NY
b Department of Neurosurgery, NYU Medical Center, New York, NY
c Department of Pathology, NYU Medical Center, New York, NY


Figure 1
View larger version (15K):

[in a new window]
  		Fig 1. The ROC curves associated with the model to diagnose high-grade tumors on the basis of rCBV, rCBV with Ktrans, and Ktrans alone. Diagnostic models based on Ktrans with rCBV and rCBV alone each had significantly higher (P < .01) area under the ROC curve (AUC = 0.94, 0.90, respectively) than did the model based on Ktrans alone (AUC = 0.63). Max indicates maximum.


Figure 2
View larger version (15K):

[in a new window]
  		Fig 2. Scatterplot of rCBV versus Ktrans shows true low-grade gliomas as crosses and true high grade gliomas as black points. The figure demonstrates that rCBV and Ktrans together are good predictors of glioma grade. The performance of the diagnostic model to predict high-grade tumors using both Ktrans and Max rCBV when overall diagnostic accuracy is highest (sensitivity = 90.7%, specificity = 76.7%) is shown.


Figure 3
View larger version (56K):

[in a new window]
  		Fig 3. A–H, Low-grade astrocytoma (grade II/IV). Top row, left to right.

A, Axial FLAIR image (TR/TE/TI, 9000/110/2500 ms) demonstrates a lesion in the left midbrain with high signal intensity and minor mass effect.

B, Axial T1-weighted postcontrast image (TR/TE, 600/14 ms; 1 excitation) demonstrates no evidence of contrast enhancement, in keeping with a low-grade astrocytoma.

C and D, Gradient-echo (TR/TE, 1000/54 ms) axial DSC MR imaging and SD25 color map suggests low permeability throughout the lesion.

E–G, Bottom row (left to right). rCBV, CBV, and CBF maps demonstrate a few foci of mildly elevated rCBV, CBV, and CBF within the glioma.

H, MTT map demonstrates some prolongation in MTT within the tumor.


Figure 4
View larger version (63K):

[in a new window]
  		Fig 4. A–H, Anaplastic astrocytoma (grade III/IV). Top row, left to right.

A, Axial FLAIR image (TR/TE/TI, 9000/110/2500 ms) demonstrates a dominant lesion in the right thalamus with extension to the left thalamus and parietooccipital region.

B, Axial T1-weighted postcontrast image (TR/TE, 600/14 ms; 1 excitation) demonstrates heterogeneous contrast enhancement in keeping with an anaplastic astrocytoma.

C, Gradient-echo axial DSC MR image (TR/TE, 1000/54 ms).

D, SD25 color map shows foci of increased permeability throughout the lesion.

E–G, Bottom row (left to right). rCBV, CBV, and CBF maps demonstrate elevated rCBV, CBV, and CBF within the glioma.

H, MTT map demonstrates some prolongation in MTT within the tumor.


Figure 5
View larger version (62K):

[in a new window]
  		Fig 5. A–H, Glioblastoma multiforme (grade IV/IV). Top row, left to right.

A, Axial FLAIR image (TR/TE/TI, 9000/110/2500 ms) demonstrates a lesion with surrounding increased signal intensity in the left parietooccipital region.

B, Axial T1-weighted postcontrast image (TR/TE, 600/14 ms; 1 excitation) demonstrates heterogeneous contrast enhancement in keeping with a glioblastoma multiforme.

C, Gradient-echo axial DSC MR image (TR/TE, 1000/54 ms).

D, SD25 color map shows foci of increased permeability anteriorly in the lesion, which appears to "washout" on the axial postcontrast T1-weighted image (arrows), possibly indicating hyperpermeability during the first pass of contrast. The areas of enhancement more posteriorly may reflect more delayed permeability.

E–G, Bottom row (left to right). rCBV, CBV, and CBF maps demonstrate elevated rCBV, CBV, and CBF within the glioblastoma multiforme.

H, MTT map demonstrates some prolongation in MTT within the tumor.





Copyright © 2008 by the American Society of Neuroradiology. Print ISSN: 0195-6108 Online ISSN: 1936-959X